The NanoB2A group focuses on the development of novel nanobiosensor devices based on plasmonics, nanoplasmonics, and silicon-based photonics principles, including surface biofunctionalization, microfluidics for automatic fluid delivery and complete lab-on-a-chip integration for point-of-care devices. The application of the nanobiosensor devices in real clinical diagnostics and environmental control is one of the Group's main objectives. The PostDoctoral position is framed within the PRIME PID2023 Project titled "Photonic nanoresonators for cancer immunotherapy evaluation" funded by AEI / MCIN, and led by Dr. Maria Soler. The candidate will participate in the different processes towards the development of a new photonic nanoresonator systems, focused on the fabrication and integration of the sensors and for their application in the evaluation of cell immunotherapies. If you are interested in joining to a young, dynamic and highly multidisciplinary team, with a highly innovative research project, this could be your opportunity.
Main Tasks and responsibilities:
The candidate will be involved in the design and development of optical label-free biosensors based on novel all-dielectric nanostructures. The main experimental tasks include: the fabrication and characterization of dielectric nanostructures; the optimization of the nanoarray geometry for application in photonic sensor systems, integration into user-friendly devices for real-time measurements; and full evaluation of the sensor prototype for refractometric biosensing measurements. The candidate will work under supervision and have the opportunity of independently developing the research. Related tasks will also include: data analysis and processing; preparation of regular reports and presentations; writing scientific publications.
Deadline for applications: 20/11/2024
Més posts de Recerca
Cap comentari:
Publica un comentari a l'entrada